Centessa Pharmaceuticals Plc ADR (CNTA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CNTA | CORT | STVN | ||
| Company | Centessa Pharmaceuticals Plc ADR | Corcept Therapeutics | Stevanato Group S.P.A. | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE | ||
| Open | 40.09 | 90.29 | 19.00 | ||
| High | 40.56 | 92.51 | 19.23 | ||
| Low | 40.00 | 89.73 | 18.79 | ||
| Latest | 40.50 | 91.19 | 19.16 | ||
| Change | +0.32 | +0.98 | +0.16 | ||
| % Change | +0.80% | +1.09% | +0.84% | ||
| Volume | 11,330,400 | 225,460 | 40,912 | ||
| 20-Day Average Volume | 2,268,790 | 969,853 | 386,368 | ||
| Previous Close | 40.18 | 90.21 | 19.00 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 39.84 | 82.74 | 17.66 | ||
| 20-Day Raw Stochastic | 93.88% | 97.17% | 83.43% | ||
| 20-Day Relative Strength | 74.36 | 80.78 | 60.95 | ||
| Weighted Alpha | +111.75 | +157.97 | -17.33 | ||
| Today's Opinion | 100% Buy | 88% Buy | 24% Buy | ||
| Previous Opinion | 100% Buy | 88% Buy | 24% Buy | ||
| Last Month's Opinion | 100% Buy | 56% Buy | 8% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +1.86% since 06/15/26 | +5.30% since 06/26/26 | +7.57% since 06/26/26 | ||
| Low | 39.66 on 06/16/26 | 86.04 on 07/01/26 | 17.23 on 06/29/26 | ||
| High | 40.56 on 06/23/26 | 92.51 on 07/06/26 | 19.23 on 07/06/26 | ||
| 1-Month | |||||
| %Chg | +1.89% since 05/22/26 | +26.61% since 06/05/26 | +3.95% since 06/05/26 | ||
| Low | 39.58 on 06/09/26 | 72.62 on 06/08/26 | 16.27 on 06/16/26 | ||
| High | 40.56 on 06/23/26 | 92.51 on 07/06/26 | 19.23 on 07/06/26 | ||
| 3-Month | |||||
| %Chg | +56.13% since 03/23/26 | +125.08% since 04/06/26 | +39.16% since 04/06/26 | ||
| Low | 25.17 on 03/24/26 | 40.36 on 04/07/26 | 13.39 on 04/10/26 | ||
| High | 40.56 on 06/23/26 | 92.51 on 07/06/26 | 19.77 on 06/05/26 | ||
| 6-Month | |||||
| %Chg | +60.33% since 12/23/25 | +156.97% since 01/06/26 | -11.12% since 01/06/26 | ||
| Low | 21.50 on 01/20/26 | 28.66 on 02/19/26 | 12.89 on 03/27/26 | ||
| High | 40.56 on 06/23/26 | 92.51 on 07/06/26 | 22.00 on 01/08/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 6,266,606 | 9,684,223 | 5,754,017 | ||
| Shares Outstanding, K | 154,731 | 107,352 | 302,843 | ||
| Annual Sales | 15,000,000 | 761,410,000 | 1,342,160,000 | ||
| Annual Net Income | -197,530,000 | 99,650,000 | 158,210,000 | ||
| Last Quarter Sales | 0 | 164,900,000 | 320,190,000 | ||
| Last Quarter Net Income | -79,240,000 | -31,760,000 | 32,810,000 | ||
| 60-Month Beta | 1.11 | 0.47 | 0.78 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.52 on 05/05/26 | -0.30 on 04/30/26 | 0.13 on 05/07/26 | ||
| Earnings Date | 08/11/26 | 07/30/26 | 08/04/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 252.80 | 29.58 | ||